10 min
The 2 Minute Medicine® Podcast- Episode 29 The 2 Minute Medicine® Podcast
-
- Health & Fitness
We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper”. Next, in the second half, we begin by discussing the UK's approval of the first licensed medication using CRISPR technology. Next, we will dive into the American Heart Association's decision to remove race as one of the biological risk factors for cardiovascular disease in their cardiac risk algorithm. Then we will discuss the news of NBA player CJ McCollum's pneumothorax, and finally we will end with a conversation about a recent finding that the life expectancy gap between men and women has widened.
We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: https://bit.ly/2zZnJt9
We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper”. Next, in the second half, we begin by discussing the UK's approval of the first licensed medication using CRISPR technology. Next, we will dive into the American Heart Association's decision to remove race as one of the biological risk factors for cardiovascular disease in their cardiac risk algorithm. Then we will discuss the news of NBA player CJ McCollum's pneumothorax, and finally we will end with a conversation about a recent finding that the life expectancy gap between men and women has widened.
We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: https://bit.ly/2zZnJt9
10 min